- Daily pill doubles survival time for pancreatic cancer patients BBC
- After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses NBC News
- ‘Landmark’ pancreatic cancer drug keeps patients alive for twice as long The Washington Post
- ASCO: RevMed confident in Ras leadership as rivals square up Fierce Biotech
- A standing ovation for RevMed, and caution for Akeso statnews.com
Source: Google Finance – Market News